• 3 October 2011

    Horizon submits NDA for RA drug

    Horizon Pharma has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for Lodotra, for the treatment of rheumatoid arthritis.

  • 2 October 2011

    Lannett Loxapine capsules get FDA approval

    The US Food and Drug Administration (FDA) has approved Lannett's abbreviated new drug application (ANDA) of Loxapine Capsules in 5mg, 10mg, 25mg and 50mg doses.

  • 29 September 2011

    AstraZeneca settles Seroquel XR dispute

    AstraZeneca has won its fight to prevent Handa Pharmaceuticals from selling a generic version of its anti-psychotic drug Seroquel XR in the US until late 2016.


Go Top